Globally, drug-resistant bacterial infections killed over 1.2 million people and played a role in 4.95 million deaths in 2019. By 2050, superbugs are expected to kill more than 10 million people each year, outpacing annual deaths from cancer.
Globally, drug-resistant bacterial infections killed over 1.2 million people and played a role in 4.95 million deaths in 2019. By 2050, superbugs are expected to kill more than 10 million people each year, outpacing annual deaths from cancer.
Since 2013, the FDA has approved 9 antibiotics from small companies. Today, all but one company behind those antibiotics have…
Read MoreThe PASTEUR Act establishes a subscription-style model for the U.S. government to secure a reliable supply of novel antimicrobials to address the…
Read MoreAntibiotic-resistant infections contributed to nearly 5 million deaths in 2019. In 2020, hospital-onset drug-resistant infections and deaths jumped 15% as…
Read MoreWhat is the superbug crisis? Superbugs are bacteria or fungi that are resistant to antibiotics and other treatments, a process…
Read More